Free Cancer Screening Guidelines
Disruptive Funding Model to Advance Innovations—A New Approach to Ending Cancer for Each and for All
The National Foundation for Cancer Research funds “high risk|high reward” research with a singular focus on one absolute and immutable goal: research to cure cancer – cures for all types of cancer. Since 1973 with grass roots support of Americans NFCR has been a catalyst for the discovery of the…...
NFCR-Affiliated Brain Cancer Scientist’s Efforts Recognized Across the Pacific
W.K. Alfred Yung, M.D., a brain cancer researcher and former National Foundation for Cancer Research fellow, was last week presented with the 3rd Annual SNOChina Award for Outstanding Contributions of International Cooperation by the Chinese Medical Doctor Association’s (CMDA) Society for Neuro-Oncology (SNO). The presentation was made at the 3rd…...
National Foundation for Cancer Research Announces Leadership Transition
FOR IMMEDIATE RELEASE: February 8, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD – The National Foundation for Cancer Research (NFCR) today announced the promotion of Sujuan Ba, Ph.D., to president and chief executive officer.…...
NFCR Links German Cancer Research Center and Chinese Medical Institutions
The National Foundation for Cancer Research (NFCR) has been promoting and facilitating collaboration among scientists from different countries, yet another role played by the organization in its efforts to help defeat the disease. Case in point: Earlier this month NFCR President Dr. Sujuan Ba played the key role in establishing…...
Medical Coalition Led Largely by NFCR Unites to Battle Glioblastoma
Medical knowledge of glioblastoma multiforme (GBM), the deadliest form of brain cancer, has grown exponentially, but has not resulted in marked improvements in treatment for patients. Addressing this is GBM AGILE (GBM Adaptive Global Innovative Learning Environment), a global medical and scientific coalition that is the first platform trial for…...
Bringing International Partners Together
(clockwise) NFCR President Dr. Sujuan Ba, ECI Founder Mr. Andrew Forrest and PhIRDA Executive President Mr. Song Ruilin In recent months, the National Foundation for Cancer Research (NFCR) has signed memorandums of understanding with two major foreign institutions, the China Pharmaceutical Innovation and Research Development Association (PhIRDA) and the Australia-based…...
NFCR at the 2018 American Association for Cancer Research Annual Meeting
The National Foundation for Cancer Research’s (NFCR) presence is considerable at the 109th annual meeting of the American Association for Cancer Research (AACR), which kicks off tomorrow in Chicago and runs through the following four days. One of the most widely anticipated regular gatherings of cancer scientists in the United…...
Global Collaborative Network Expands to Include Australia’s Eliminate Cancer Initiative
The National Foundation for Cancer Research (NFCR) today inked its second memorandum of understanding (MOU) within the past half year among major transnational cancer-fighting institutions. This pledge of cooperation follows on the heels of the formal commitment between the chairmen of itself and the China Pharmaceutical Innovation and Research Development…...
NFCR Leads Delegation to Chinese BioMed Conference, Signs MOU with Host
The National Foundation for Cancer Research, led by Chairman Joseph F. Franlin and President Sujuan Ba, recruited a delegation of eight U.S. cancer technology start-ups for a successful exploratory mission to China. The companies—ArrayBio, Eutropics, Immix Biopharma, InterLeukin Therapeutics, International Cancer Impact Fund, InVaMet Therapeutics, Nonpareil Biotechnologies and Stromatis Pharma—were…...
- 1
- 2